Thu, February 1, 2024

David Nierengarten Reiterated (TCRX) at Buy and Held Target at $9 on, Feb 1st, 2024

David Nierengarten of Wedbush, Reiterated "TScan Therapeutics, Inc." (TCRX) at Buy and Held Target at $9 on, Feb 1st, 2024.

David, nor any peers, have made any analyst calls on TCRX in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30